iCS-digital kit and software

Discover the first digital PCR kit to detect the most frequent genomic abnormalities reported in human pluripotent stem cells

Stem Genomics diversifies its offer by launching the iCS-digital TM PSC kit, allowing you to perform this test, already offered in service for more than 2 years, in your facilities.
The iCS-digital TM PSC kit is a precise, fast and sensitive digital PCR test for the detection of more than 90% of the recurrent genomic abnormalities in hPSCs. The iCS-digital TM PSC kit includes eight multiplexed PCR assays that allow the reliable analysis of the 24 regions with the most frequent Copy Number Variations (CNVs) reported in hPSCs. The kit also includes a validated normal genomic DNA control (XY).
Data processing, statistical analysis, and graphical representation of the results can be performed in an automated and explicit way using the iCS-digital TM software provided online by Stem Genomics to help users with data interpretation.

Latest news

discover and share

The discovery and recent advances in the CRISPR/Cas9 gene-editing technology have profoundly reshaped the field of genome engineering and allowed the generation of a wide range of mutant cell lines at an unprecedented rate. However, CRISPR/Cas9 gene editing in hPSCs can also pose a threat to the overall genomic integrity. Why? To know more, have a look at our July newsletter!

Stem cells are the heart of many of tomorrow personalized therapies. Join us at the most comprehensive meeting in stem cell science, the ISSCR 2021. It will take place virtually from 21 to 26 June 2021. Discover our services for your stem cell research projects and meet us at our booth during this virtual event! We are eager to answer any questions you might have.

Stay informed

Subscribe to our newsletter

Subscribe to our newsletter
By subscribing, you authorize Stem Genomics to register your email address. We will only use your email address to send you our newsletter. We respect your data and follow GDPR. Please see our privacy policy for further details.